Monumen-TAL progress in the treatment of relapsed multiple myeloma

Susan Bal¹

Affiliations

Affiliation

¹ Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: susanbal@uabmc.edu.

PMID: 40090351
DOI: 10.1016/S2352-3026(25)00009-2

Comment

Monumen-TAL progress in the treatment of relapsed multiple myeloma

Susan Bal. Lancet Haematol. 2025 Apr.

. 2025 Apr;12(4):e235-e236.

doi: 10.1016/S2352-3026(25)00009-2. Epub 2025 Mar 13.

Author

Susan Bal¹

Affiliation

¹ Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: susanbal@uabmc.edu.

PMID: 40090351
DOI: 10.1016/S2352-3026(25)00009-2

No abstract available

PubMed Disclaimer

Conflict of interest statement

I have received research funding from Bristol Myers Squibb, Fate Therapeutics, Beigene and honoraria from AbbVie, AstraZeneca, Adaptive Biotechnologies, Bristol Myers Squibb, Janssen, Pfizer, and MJH Lifesciences.

Comment on

Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1-2 study.
Chari A, Touzeau C, Schinke C, Minnema MC, Berdeja JG, Oriol A, van de Donk NWCJ, Rodríguez-Otero P, Morillo D, Martinez-Chamorro C, Mateos MV, Costa LJ, Caers J, Rasche L, Krishnan A, Ye JC, Karlin L, Lipe B, Vishwamitra D, Skerget S, Verona R, Ma X, Qin X, Ludlage H, Campagna M, Masterson T, Hilder B, Tolbert J, Renaud T, Goldberg JD, Kane C, Heuck C, San-Miguel J, Moreau P. Chari A, et al. Lancet Haematol. 2025 Apr;12(4):e269-e281. doi: 10.1016/S2352-3026(24)00385-5. Epub 2025 Mar 13. Lancet Haematol. 2025. PMID: 40090350 Clinical Trial.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Monumen-TAL progress in the treatment of relapsed multiple myeloma

Affiliation

Monumen-TAL progress in the treatment of relapsed multiple myeloma

Author

Affiliation

Conflict of interest statement

Comment on

References

Publication types

LinkOut - more resources

Full Text Sources

Miscellaneous